340B Drug Discount Program: Compliance and Recent Developments (July 2017)
In this webinar, members of FTLF’s 340B/Pharmacy team will provide an overview of the 340B Drug Discount Program, discuss the program’s requirements, and outline recent developments and compliance implications for covered entities. Michael Glomb, Jason Reddish, and Elizabeth (Issie) Karan will explore important issues including patient eligibility, contract pharmacy and vendor arrangements, 340B program audits, Medicaid reimbursement, and related topics.
A partner with the firm, Mike practices in the Federal Grants and Health Law groups, and has over three decades of experience advising community-based organizations on a broad range of legal matters. Specifically, he offers guidance to Federally Qualified Health Centers, other federal grantees, and several professional and trade associations on the 340B drug discount program, tax exemption, grants law, and fraud matters. [Full Bio]
Jason focuses his practice on the federal 340B drug discount program and the complex legal and compliance issues facing safety net providers, pharmacies, and other 340B program stakeholders. Jason began his career representing pharmaceutical manufacturers before finding his passion helping 340B program covered entities, including disproportionate share hospitals, Federally Qualified Health Centers, Ryan White HIV/AIDS clinics, and other grantees navigate the 340B program. [Full Bio]
Elizabeth (Issie) Karan
Elizabeth is an associate working in the firm’s Health Law and Federal Grants practice groups counseling a diverse array of organizations including Hemophilia Treatment Centers, Federally Qualified Health Centers, primary care associations, and other Federal grantees. Elizabeth’s practice focuses mainly on assisting clients with the 340B drug pricing program, grants compliance, provider collaborations, Medicaid and Medicare reimbursement issues, and implementation of the Affordable Care Act. [Full Bio]
Certificates of Attendance are available for all webinars (both live and recorded) for the registered attendee upon completion of the webinar.
A blank Certificate of Attendance will be available for organizations to issue to attendees that viewed the webinar (either live or on-demand). Due to the online nature of the training course, Feldesman Tucker Leifer Fidell LLP does not certify that the attendee actually viewed the course. A supervisor at the organization should sign the certificate, and therefore, certifies that the attendee viewed the course.
Attendance record forms are available for all webinars (live and on-demand) and can be utilized to record the attendance of numerous staff members for internal purposes.
Recorded webinars are available for 60 days after the date of purchase or date of the webinar. Once your purchase is complete, you can re-access the webinar at any time by clicking “My Account” in the upper right hand corner of the page or by selecting it from the “My Training” box on the FTLF Learning Center homepage.
An unlimited number of participants can experience a live or recorded webinar by broadcasting it on a projection screen and watching it together. A single login can gain access to the webinar and be issued a certificate. The record of attendance form can be accessed under the certificate link within the activity. For information on registering for live and recorded webinars, please refer to our FAQ section.
If you selected a payment option other than Credit Card, access to the on-demand webinar will be granted within 3 business days. Once you are granted access you will receive a confirmation email. FTLF reserves the right to suspend access to the webinar if payment is not received within 30 days.
REFUND/ CANCELLATION POLICY
No refunds are provided for recorded webinars. FTLF can accommodate transferring the registration to someone else within your organization or transferring the registration to another on-demand or upcoming live webinar provided that the webinar has not been viewed.
Google Chrome and Mozilla Firefox are the preferred browsers.